CHMP5 and Autoimmunity: In conclusion, patients with 1-year duration long-COVID-19 syndrome exhibit a distinct immunologic phenotype that includes decreased levels of anti-SARS-CoV-2 anti-spike and neutralizing antibodies, autoimmunity, and low-degree chronic inflammation that tends to dissipate.